Join us on 12-15-2022 for a live seminar about RNA SEQ

Click Here

Thank you for reaching out to Alloy Tx

Join our Webinar Tuesday February 14th at 11:30am ET
Or register to receive the recording if you can’t make it live

TCR mimics (TCRm) and engineered TCRs enable drug developers to work against the vast space of intracellular proteins (>70% of the human proteome) that have not been addressed by conventional cancer immunotherapies. Despite tremendous potential therapeutic values, the discovery of highly specific TCRm and TCR-based therapeutics remains a challenge for many due to inaccessibility to the required foundational technologies. Alloy’s Keyway TCR Discovery group provides comprehensive proprietary technology and capabilities for the end-to-end discovery of these modalities. In this webinar, leading scientists at the helm of Keyway TCRm Discovery campaigns will present:
1. An overview of common challenges to intracellular protein-targeting drug discovery
2. Keyway’s industry-leading solutions to TCRm/TCR-based therapeutic discovery including its proprietary specificity screening and high-quality pMHC complex antigen production capabilities
3. A case study featuring the discovery of a panel of highly specific, functional TCRm binders against an intracellular immuno-oncology target
Join us for an informative discussion, and be sure to bring your questions. 

Our team has received your request and we will follow up with you shortly. 

Follow us and connect on LinkedIn

Review our recent Case Studies

Accept Privacy Settings Here
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please read and Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound